Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Revenue

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹270 Cr₹293 Cr₹241 Cr₹336 Cr₹279 Cr

What is the latest Revenue of BALAXI PHARMACEUTICALS ?

The latest Revenue ratio of BALAXI PHARMACEUTICALS is ₹270 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹270 Cr
Mar2025₹293 Cr
Mar2024₹241 Cr
Mar2023₹336 Cr
Mar2022₹279 Cr

How is Revenue of BALAXI PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹270 Cr
-7.65
Mar2025 ₹293 Cr
21.25
Mar2024 ₹241 Cr
-28.28
Mar2023 ₹336 Cr
20.42
Mar2022 ₹279 Cr -

Compare Revenue of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹127.1 Cr 0.4% 2.1% -50.1% Stock Analytics
ADANI ENTERPRISES ₹401,514.0 Cr -0.8% -6.3% 9.1% Stock Analytics
ADITYA INFOTECH ₹46,782.8 Cr -0.3% 6.7% 167.3% Stock Analytics
AEGIS LOGISTICS ₹45,677.4 Cr -7.4% 0.9% 67.4% Stock Analytics
PREMIER ENERGIES ₹39,675.4 Cr -4% -13.8% -10.4% Stock Analytics
REDINGTON ₹31,700.9 Cr 1.1% 10.8% 41.9% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

0.4%

2.1%

-50.1%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses